References
- Salim M, Liu Y, Sorkhei M, et al. AI-based selection of individuals for supplemental MRI in population-based breast cancer screening: the randomized ScreenTrustMRI trial. Nat Med. 2024; 30(9), 2623-2630. DOI: 10.1038/s41591-024-03093-5
- Kalia M. Biomarkers for personalized oncology: Recent advances and future challenges. Metabolism. 2015;64(3):S16-21. DOI: 10.1016/j.metabol.2014.10.027
- Tarighati E, Keivan H, Mahani H. A review of prognostic and predictive biomarkers in breast cancer. Clini experimental med. 2022; 23(1):1-16. DOI: 10.1007/s10238-021-00781-1
- Alismail H. Merging from traditional to potential novel breast cancer biomarkers. Journal of King Saud University-Science. 2024; 103551. DOI: 10.1016/j.jksus.2024.103551
- Donthu N, Kumar S, Mukherjee D, Pandey N, Lim, WM. How to conduct a bibliometric analysis: An overview and guidelines. J Bus Res. 2021;133:285-96. DOI: 10.1016/j.jbusres.2021.04.070
- Chakraborty S, Sharma G, Karmakar S, Banerjee S. Multi-OMICS approaches in cancer biology: New era in cancer therapy. Biochim Biophys Acta Mol Basis Dis. 2024;1870(5). DOI: 10.1016/j. bbadis.2024.167120
- Yıllık PA Bibliometric Analysis of Wearable Health Technology Research. Bilge International Journal of Science and Technology Research. 2023;7(2):187-97. DOI: 10.30516/bilgesci.1358090
- Aria M, Cuccurullo C. Bibliometrix: An R-tool for comprehensive science mapping analysis. J Informetr. 2017;11(4):959-75. DOI: 10.1016/j.joi.2017.08.007
- Jain J, Walia N, Singh S, et al. Mapping the field of behavioural biases: a literature review using bibliometric analysis. Management Review Quarterly 2022;72(3):823-55. DOI: 10.1007/s11301-021-00215-y
- Gu Y, Han F, Xue M, Wang M, Huang Y. Breast cancer screening and early diagnosis in China: a systematic review and meta-analysis on 10.72 million women. BMC Womens Health. 2024;24(1). DOI: 10.1186/s12905-024-02924-4
- Obeagu EI, Obeagu GU. Breast cancer: A review of risk factors and diagnosis. Medicine. 2024;103(3):E36905. DOI: 10.1097/MD.0000000000036905
- Wadasadawala T, Mohanty SK, Sen S, Kanala TS, Maiti S, Puchali N, et al. Out-of-pocket payment and financial risk protection for breast cancer treatment: a prospective study from India. The Lancet Regional Health - Southeast Asia. 2024;24. DOI: 10.1016/j.lansea.2023.100346
- Liang X, Vacher S, Boulai A, Bernard V, Baulande S, Bohec M, et al. Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer. Breast Cancer Research. 2018;20(1). DOI: 10.1186/s13058-018-1007-x
- Corti G, Buchet R, Magrini A, Ciancaglini P, Mebarek S, Bottini M. The surface proteomic profile of serum extracellular vesicles as a diagnostic and prognostic tool in breast cancer., Current Opinion in Physiology. 2024; 100734. DOI: 10.1016/j.cophys.2023.100734
- Patel SA, Hassan MK, Naik M, Mohapatra N, Balan P, Korrapati PS, et al. EEF1A2 promotes HIF1A mediated breast cancer angiogenesis in normoxia and participates in a positive feedback loop with HIF1A in hypoxia. Br J Cancer. 2024;130(2):184-200. DOI: 10.1038/s41416-023-02509-2
- Shi, Y, Guo Z, Wang Q, Deng H. Prognostic value of tumor-infiltrating lymphocyte subtypes and microorganisms in triple-negative breast cancer. J Cancer Res Ther 2024;20(7):1983-90. DOI: 10.4103/jcrt.jcrt_41_24
- Howard FM, Olopade OI. Epidemiology of triple-negative breast cancer: a review. The Cancer Journal. 2021; 27(1):8-16. DOI: 10.1097/PPO.0000000000000500
- Yoon J, Oh DY. HER2-targeted therapies beyond breast cancer - an update. Vol. 21, Nature Reviews Clinical Oncology. Springer Nature. 2024; 675-700. DOI: 10.1038/s41571-024-00924-9
- Herath A. Multimodal Contrastive Clustering: Deep Unsupervised Learning Approach for Cancer Subtype Discovery with Multi-omics Data. Master’s thesis, University of Windsor 2024. DOI: 10.1016/j.procs.2024.09.488
- Singh D, Assaraf YG, Gacche RN. Long non-coding RNA mediated drug resistance in breast cancer. Drug Resistance Updates. 2022;63. DOI: 10.1016/j.drup.2022.100851
- Darbandi MR, Darbandi M, Darbandi S, Bado I, Hadizadeh M, Khorshid HRK. Artificial intelligence breakthroughs in pioneering early diagnosis and precision treatment of breast cancer: A multimethod study. Eur J Cancer 2024; 114227. DOI: 10.1016/j.ejca.2024.114227